Toward global standardization of conducting fair investigations of allegations of research misconduct.


Journal

Accountability in research
ISSN: 1545-5815
Titre abrégé: Account Res
Pays: United States
ID NLM: 9100813

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 1 4 2020
medline: 22 7 2021
entrez: 1 4 2020
Statut: ppublish

Résumé

In the United States, through nation-wide discussions, the procedures for handling allegations of research misconduct are now well established. Procedures are geared toward carefully treating both complainants and respondents fairly in accordance with the US framework. Other countries, which have their own cultural and legal framework, also need fair and legally compatible procedures for conducting investigations of allegations of research misconduct. Given the rapid growth of international collaboration in research, it is desirable to have a global standard, or common ground, for misconduct investigations. Institutions need clear guidance on important subjects such as what information should be included in the investigation reports, how the investigation committee should be organized once research misconduct allegation has been received, how to conduct the investigation, how the data and information obtained should be taken as evidence for vs. against misconduct, and what policies the investigation committee should follow. We explore these issues from the viewpoint of members of committees investigating accusations of research misconduct (hereafter referred to as "investigation committees") as well as persons overseeing the committees in Japan. We hope to engender productive discussions among experts in misconduct investigations, leading to a formulation of international standards for such investigation.

Identifiants

pubmed: 32223327
doi: 10.1080/08989621.2020.1747019
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-346

Auteurs

Rei Nouchi (R)

Division of Research Integrity and Ethics, School of Medicine, Shinshu University , Matsumoto, Nagano, Japan.

Hiroaki Aihara (H)

School of Science, The University of Tokyo , Bunkyo-ku, Tokyo, Japan.
Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.

Fumie Arie (F)

Translational Medical Center, National Center of Neurology and Psychiatry , Kodaira, Tokyo, Japan.

Makoto Asashima (M)

President, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.
Strategic Innovation and Research Center, Teikyo University , Itabashi-ku, Tokyo, Japan.

Hiroyuki Daida (H)

Faculty of Health Science, Juntendo University , Bunkyo-ku, Tokyo, Japan.

Jun Fudano (J)

Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.
Tokyo Tech Academy for Leadership, Tokyo Institute of Technology , Meguro-ku, Tokyo, Japan.

Yasuhiro Fujiwara (Y)

Chief Executive, Pharmaceuticals and Medical Devices Agency , Chiyoda-ku, Tokyo, Japan.

Shinji Fushiki (S)

The Center for Quality Assurance in Research, Kyoto Prefectural University of Medicine , Kamigyo-ku, Kyoto, Japan.

Robert J Geller (RJ)

School of Science, The University of Tokyo , Bunkyo-ku, Tokyo, Japan.

Kazuo Hatano (K)

The Center for Quality Assurance in Research, Kyoto Prefectural University of Medicine , Kamigyo-ku, Kyoto, Japan.
Research Regulatory Management, Astellas Pharm. Inc ., Tsukuba, Ibaraki, Japan.

Toshio Homma (T)

Visiting Researcher, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.

Minoru Kimura (M)

Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.
The Institute of Medical, SciencesTokai University , Isehara, Kanagawa, Japan.

Toshio Kuroki (T)

Research Center for Science Systems, Japan Society for the Promotion of Science , Chiyoda-ku, Tokyo.

Koichi Miki (K)

Law School, Keio University , Minato-ku, Tokyo, Japan.

Ikuo Morita (I)

Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.
Trustee, Vice-President, Ochanomizu University , Bunkyo-ku, Japan.

Kosaku Nitta (K)

Department of Nephrology, Tokyo Women's Medical University , Shinjuku-ku, Tokyo, Japan.

Akira Shinohara (A)

Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Tokyo, Japan.
Institute for Protein Research, Osaka University , Suita, Osaka, Japan.

Mikiko C Siomi (MC)

School of Science, The University of Tokyo , Bunkyo-ku, Tokyo, Japan.

Masayuki Yoshida (M)

Bioethics Research Center, Tokyo Medical and Dental University , Bunkyo-ku, Tokyo, Japan.

Iekuni Ichikawa (I)

Division of Research Integrity and Ethics, School of Medicine, Shinshu University , Matsumoto, Nagano, Japan.
Executive Director, Association for the Promotion of Research Integrity , Shinjuku-ku, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH